BioPharm.Si (Q3270309): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in it, and other parts: Adding Italian translations) |
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
||||||||||||||
label / es | label / es | ||||||||||||||
BioPharm.Si | |||||||||||||||
Property / summary | |||||||||||||||
Nueva Generación de Drogas Biológicas (Spanish) | |||||||||||||||
Property / summary: Nueva Generación de Drogas Biológicas (Spanish) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: Nueva Generación de Drogas Biológicas (Spanish) / qualifier | |||||||||||||||
point in time: 13 January 2022
|
Revision as of 07:01, 13 January 2022
Project Q3270309 in Slovakia
Language | Label | Description | Also known as |
---|---|---|---|
English | BioPharm.Si |
Project Q3270309 in Slovakia |
Statements
4,777,897.3 Euro
0 references
5,972,371.63 Euro
0 references
80.0 percent
0 references
7 July 2016
0 references
31 December 2021
0 references
CO BIK
0 references
0 references
5270
0 references
Nova Generacija bioloških zdravil (Slovenian)
0 references
Identifiers
OP20.00363
0 references